HDAC6 and familial pancreatic carcinoma: As shown in Fig. 4E–G, in agreement with the HDAC6 siRNA results, overexpression of HDAC6 or its catalytically inactive mutant did not significantly affect the proliferation or cell cycle progression of pancreatic cancer cells.